(Q37350172)

19 August 2017

1 reference

title

High-density lipoprotein/apolipoprotein A-I infusion therapy (English)

1 reference

19 August 2017

1 reference

1

Jean-Claude Tardif

1 reference

19 August 2017

Therese Heinonen

2

1 reference

19 August 2017

Stephane Noble

series ordinal

3

1 reference

19 August 2017

publication date

1 January 2009

1 reference

Current Atherosclerosis Reports

19 August 2017

published in

1 reference

19 August 2017

volume

11

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

58-63

1 reference

HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0009-7

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0009-7

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0009-7

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0009-7

Prognostic significance of progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0009-7

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

12 December 2020

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

12 December 2020

The clinical significance of serum high density lipoproteins

1 reference

12 December 2020

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

1 reference

12 December 2020

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits

1 reference

12 December 2020

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

1 reference

12 December 2020

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

12 December 2020

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

12 December 2020

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

12 December 2020

Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans

1 reference

12 December 2020

Effects of torcetrapib in patients at high risk for coronary events

1 reference

12 December 2020

Endothelial and antithrombotic actions of HDL.

1 reference

12 December 2020

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial

1 reference

12 December 2020

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

12 December 2020

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

1 reference

12 December 2020

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

1 reference

12 December 2020

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

1 reference

12 December 2020

High-density lipoproteins enhance progenitor-mediated endothelium repair in mice

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

High density lipoprotein and other lipoproteins in normolipidaemic and hypertriglyceridaemic (type IV) men with coronary artery disease

1 reference

12 December 2020

Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group

1 reference

12 December 2020

Artificial HDL as an anti-atherosclerotic drug

1 reference

12 December 2020

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

1 reference

12 December 2020

Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

12 December 2020

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Evidence that reverse cholesterol transport occurs in vivo and requires lecithin-cholesterol acyltransferase

1 reference

12 December 2020

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

12 December 2020

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

12 December 2020

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

1 reference

12 December 2020

Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis

1 reference

12 December 2020

Low HDL cholesterol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol

1 reference

12 December 2020

Reverse cholesterol transport from fibroblasts to high density lipoproteins: computer solutions of a kinetic model

1 reference

12 December 2020

Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11883-009-0009-7

Identifiers

DOI

1 reference

19 August 2017

1 reference